Dagco »

Crispr Therapeutics shares owned by Dagco

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Dagco from 13F filings

Historical chart of Dagco investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Dagco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Dagco

Quarter filed Position value Share count Share price at filing
2024-09-30 $611 13 47.00
2024-03-31 $885 13 68.15

More positions owned by Dagco

Ishares Tr Core Div Grwth (DGRO)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Global X Fds S&p 500 Catholic (CATH)
Microsoft Corporation (MSFT)
First Tr Exchange Traded Cap Strength Etf (FTCS)

View all positions for Dagco

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
BlackRock
T. Rowe Price Investment Management
State Street Corporation
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics